Exzell Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity (NCT02810301) | Exzell Pharma Inc. | 2016-04-01 |
Track Exzell Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.